Clinical Trial Update: A Study to Assess the Safety and Efficacy of ADVAGRAF (Tacrolimus Modified Release Formulation) in Kidney Transplant Patients Who Were Treated With PROGRAF [Phase 4]

View source ↗

Summary

A Phase 4 study evaluated the safety and efficacy of ADVAGRAF (tacrolimus modified-release) in kidney transplant patients who had previously been treated with P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Advagraf (tacrolimus)
• Prograf (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Korea, Inc. | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED